Zhu B - Search Results

1

Economic outcomes associated with switching individuals with schizophrenia between risperidone and olanzapine: findings from a large US claims database.

Zhao Z, Namjoshi M, Barber BL, Loosbrock DL, Tunis SL, Zhu B, Breier A. Zhao Z, et al. Among authors: zhu b. CNS Drugs. 2004;18(3):157-64. doi: 10.2165/00023210-200418030-00002. CNS Drugs. 2004. PMID: 14871159

2

Clinical comparability of schizophrenia patients at two public mental health systems.

Ascher-Svanum H, Zhu B, Stensland MD, Sterling K. Ascher-Svanum H, et al. Among authors: zhu b. Adm Policy Ment Health. 2003 Jan;30(3):231-45. doi: 10.1023/a:1023580309681. Adm Policy Ment Health. 2003. PMID: 12854678

3

A comparison of olanzapine and risperidone on the risk of psychiatric hospitalization in the naturalistic treatment of patients with schizophrenia.

Ascher-Svanum H, Zhu B, Faries D, Ernst FR. Ascher-Svanum H, et al. Among authors: zhu b. Ann Gen Hosp Psychiatry. 2004 Jun 2;3(1):11. doi: 10.1186/1475-2832-3-11. Ann Gen Hosp Psychiatry. 2004. PMID: 15175112 Free PMC article.

4

Service utilization and costs of olanzapine versus divalproex treatment for acute mania: results from a randomized, 47-week clinical trial.

Zhu B, Tunis SL, Zhao Z, Baker RW, Lage MJ, Shi L, Tohen M. Zhu B, et al. Curr Med Res Opin. 2005 Apr;21(4):555-64. doi: 10.1185/030079905X38259. Curr Med Res Opin. 2005. PMID: 15899104 Clinical Trial.

5

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics.

Faries D, Ascher-Svanum H, Zhu B, Correll C, Kane J. Faries D, et al. Among authors: zhu b. BMC Psychiatry. 2005 May 27;5:26. doi: 10.1186/1471-244X-5-26. BMC Psychiatry. 2005. PMID: 15921508 Free PMC article. Clinical Trial.

6

Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia.

Ascher-Svanum H, Zhu B, Faries D, Landbloom R, Swartz M, Swanson J. Ascher-Svanum H, et al. Among authors: zhu b. BMC Psychiatry. 2006 Feb 21;6:8. doi: 10.1186/1471-244X-6-8. BMC Psychiatry. 2006. PMID: 16504026 Free PMC article. Clinical Trial.

7

Medication patterns and costs associated with olanzapine and other atypical antipsychotics in the treatment of bipolar disorder.

Zhu B, Kulkarni PM, Stensland MD, Ascher-Svanum H. Zhu B, et al. Curr Med Res Opin. 2007 Nov;23(11):2805-14. doi: 10.1185/030079907x233322. Curr Med Res Opin. 2007. PMID: 17910804

8

Cost of antipsychotic polypharmacy in the treatment of schizophrenia.

Zhu B, Ascher-Svanum H, Faries DE, Correll CU, Kane JM. Zhu B, et al. BMC Psychiatry. 2008 Apr 4;8:19. doi: 10.1186/1471-244X-8-19. BMC Psychiatry. 2008. PMID: 18394168 Free PMC article.

9

Costs of treating patients with schizophrenia who have illness-related crisis events.

Zhu B, Ascher-Svanum H, Faries DE, Peng X, Salkever D, Slade EP. Zhu B, et al. BMC Psychiatry. 2008 Aug 26;8:72. doi: 10.1186/1471-244X-8-72. BMC Psychiatry. 2008. PMID: 18727831 Free PMC article.

10

The cost of comorbid depression and pain for individuals diagnosed with generalized anxiety disorder.

Zhu B, Zhao Z, Ye W, Marciniak MD, Swindle R. Zhu B, et al. J Nerv Ment Dis. 2009 Feb;197(2):136-9. doi: 10.1097/NMD.0b013e3181963486. J Nerv Ment Dis. 2009. PMID: 19214050

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,422 results

Search Page

Filters